Nanox Vision

Medical Imaging Technology and Solutions

Health Tech & Life Sciences
Public on NASDAQ on Aug 2020

Company Overview

Snapshot

Founded in December 2018, Nanox Vision operates with 51–200 employees and has raised a total of $345 million across 7 funding rounds from 6 investors. The company went public on NASDAQ in August 2020.

Business overview

Nanox Vision is a Health Tech & Life Sciences company focused on advancing preventive healthcare through affordable medical imaging technologies and advanced AI. The company's ecosystem includes Nanox.ARC, a multi-source Digital Tomosynthesis system; Nanox.AI, an AI-based suite of algorithms for early detection of chronic diseases; Nanox.CLOUD, a cloud-based software platform for data management and imaging analysis; and Nanox.MARKETPLACE, a decentralized platform providing remote access to radiology and cardiology experts. Nanox serves the healthcare industry by providing end-to-end solutions from scan to diagnosis, leveraging AI for improved diagnostics and better health outcomes.

Strategic signal

In November 2025, Nanox.AI's Bone Solutions, an advanced AI-powered software for spine assessment, was recommended by NICE for Early Value Assessment in UK National Health Service hospitals. This signals significant market validation and potential for broader adoption of Nanox's AI diagnostic tools within major healthcare systems, indicating a strong forward trajectory in AI-driven medical diagnostics.

Company Intelligence Q&A

When did Nanox Vision go public?
Nanox Vision went public on NASDAQ in August 2020.
What was a key strategic partnership for Nanox in 2025?
In September 2025, Nanox partnered with Monarch Medical Management to expand access to advanced 3D imaging and multi-segment healthcare solutions.
What significant manufacturing agreement did Nanox announce in October 2023?
In October 2023, Nanox announced a strategic manufacturing agreement with Varex Imaging Corporation to advance the Nanox.ARC Medical Imaging System.
What was a notable AI solution development for Nanox.AI in September 2023?
In September 2023, Nanox.AI’s HealthCCSng AI Solution revealed that approximately 60% of patients in a study had previously undetected risk of a cardiovascular event from routine chest CTs.
What was a key development for Nanox.AI in November 2025?
In November 2025, Nanox.AI Bone Solutions, an advanced AI-powered software for spine assessment, was recommended by NICE for Early Value Assessment in UK National Health Service hospitals.

External links